FIELD: medicine, more particularly treatment of ecological diseases. SUBSTANCE: oncological agents include azole containing ferrorene derivatives such as ferrocenylalkyl polyfluoroazoles of general formula: 
wherein R is H; X is CH3,(1) or R is H, X is CHF-CF3; (2) or R is H, X is CF2-CHF2; (3) or R is H; X is CHF-O-CF3; (4) or R is CH3, X is CHF-CF3. EFFECT: improved properties. 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 1-(1,1,1,3,3,3-HEXAFLUORO-2-FERROCENYLPROP-2-YL)-IMIDAZOLE, POSSESSING ANTITUMOUR ACTIVITY AND METHODS OF OBTAINING THEREOF (VERSIONS) | 2013 |
|
RU2533823C1 |
| METHOD OF SYNTHESIS OF 2-(α-HYDROPOLYFLUOROALKYL)-BENZIMIDAZOLES | 1994 |
|
RU2064929C1 |
| TARTRATE DERIVATIVES APPLIED AS BLOOD COAGULATION FACTOR IXA INHIBITORS | 2007 |
|
RU2446160C2 |
| FERROCENYLALKYL DERIVATIVES OF DIPYRAZOLYLSELENIDES AS BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS FOR PRODUCTION THEREOF (VERSIONS) | 2019 |
|
RU2714891C1 |
| THERAPEUTIC AGENTS BASED ON DIGLYCYLYL ETHER DERIVATIVES AND METHODS FOR USING THEM | 2009 |
|
RU2572596C2 |
| N,N-BIS-(POLYFLUOROALKYL)AMIDOSULFOFLUORIDES SHOWING INSECTICIDAL ACTIVITY OF FUMIGATION ACTION | 1989 |
|
SU1746664A1 |
| METHOD FOR OBTAINING SUBSTITUTED IMIDAZOLE OR ITS NONTOXIC PHARMACEUTICALLY ACCEPTABLE ACID-ADDITIVE SALT | 0 |
|
SU1836355A3 |
| SUBSTITUTED DI-(FORMYLARYL)-POLYESTERS OR THEIR COORDINATION COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE ADDITIVE SALTS, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION ON SAID | 1998 |
|
RU2137750C1 |
| ISOSERINE DERIVATIVES APPLIED AS BLOOD COAGULATION FACTOR IXA INHIBITORS | 2007 |
|
RU2446157C2 |
| BINUCLEAR NITROSYL IRON COMPLEXES WITH BENZAZEHETEROCYCLIC DERIVATIVES, WAYS OF ITS PRODUCTION | 2007 |
|
RU2441872C2 |
